Warren Eric

Chief Commercial Officer

1 company

Good

Trades Analyzed

12M Win Rate

38.5%

Avg 3M Return

+7.7%

Avg 12M Return

-1.6%

Warren Eric is a Chief Commercial Officer at Esperion Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $1.2M based on current market prices.

Holdings by Company

ESPRApr 17, 2025

Current Shares370.2K

Value$1.17M

Net Activity-19,188

Bought: 1.0KSold: 20.2K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 17, 2025	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	108	$0.98	$105.62	-	+17.9%	-
Mar 18, 2025	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	2,433	$1.49	$3,617.87	-0.7%	-25.9%	+58.9%
Feb 19, 2025	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	239	$1.87	$446.45	-0.1%	-52.2%	+85.3%
Jan 17, 2025	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	123	$2.26	$277.98	-	-57.0%	+37.6%
Dec 17, 2024	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	2,234	$2.43	$5,426.39	-1.4%	-37.4%	+48.4%
Nov 19, 2024	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	197	$2.17	$426.51	-0.1%	-22.4%	+15.8%
Oct 17, 2024	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	107	$2.12	$226.73	-	+4.7%	+30.3%
Sep 17, 2024	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	2,608	$1.78	$4,650.06	-1.6%	+30.9%	+52.8%
Aug 19, 2024	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	211	$1.95	$410.61	-0.1%	+13.2%	+7.4%
Jul 17, 2024	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	108	$2.59	$279.40	-	-18.7%	-52.7%